Patents
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
10/2008
10/08/2008EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
09/2008
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429593 Utilities of amide compounds
09/25/2008WO2008114279A2 Novel polymorphs of lamivudine
09/25/2008WO2008114023A2 Phthalazinone derivatives
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/16/2008US7425568 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias
09/11/2008US20080221086 Novel Inhibitors of Glutaminyl Cyclase
09/10/2008EP1362856B1 Water-soluble triazole fungicide
09/09/2008US7423048 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release
09/09/2008CA2211646C Substituted phenyl compounds as endothelin antagonists
09/02/2008US7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
08/2008
08/27/2008EP1620431B1 3-carbonylaminothiophenes and their use as fungicides
08/26/2008US7417150 Azoles having an insecticidal action
08/12/2008US7410972 Compounds
08/12/2008US7410961 2,6-disubstituted piperiddines as modulators
08/06/2008CN100408570C EP4 receptor antagonists
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma
08/05/2008CA2331593C Metabolites of ecteinascidin 743
07/2008
07/30/2008EP1948642A1 4-heteroarymethyl substituted phthalazinone derivatives
07/30/2008CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
07/22/2008US7402588 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
07/17/2008WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk
07/16/2008EP1943246A1 Aspartyl protease inhibitors
07/16/2008CN101223155A Benzoheterocyclylethylcarboxamide derivatives
07/16/2008CN100402525C Pyridine derivatives as fungicidal compounds
07/15/2008US7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/08/2008US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
07/03/2008CA2673003A1 Quinazolines for pdk1 inhibition
06/2008
06/26/2008WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
06/25/2008EP1606266A4 Chemical compounds
06/25/2008EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph
06/04/2008EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
06/03/2008US7381743 Macrocycles for the treatment of cancer
06/03/2008US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders
06/03/2008US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide
05/2008
05/29/2008WO2008040669A3 Novel intermediates for the preparation of a glyt1 inhibitor
05/22/2008WO2008061029A1 Aryl sulfonamide derivatives and methods of their use
05/21/2008EP1603893B1 Ep4 receptor antagonists
05/20/2008US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
05/08/2008US20080108666 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides
05/08/2008US20080108665 [1-(6-chloropyridin-3-yl)ethyl](methyl)oxido- lambda 4-sulfanylidenecyanamide; Insecticides; potentiation; atypical mode of action; effective control in agricultural, urban and/or animal health systems by applying to a locus ; control of foliar-feeding insects
05/08/2008US20080108595 Inhibitors of cathepsin s
05/08/2008CA2667891A1 An improved process for the manufacture of lamivudine
05/06/2008US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
05/06/2008US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/02/2008CA2667435A1 Chemical compounds
04/2008
04/22/2008US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
04/22/2008CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
04/16/2008CN101163478A Compounds for inflammation and immune-related uses
04/10/2008WO2008040669A2 Novel intermediates for the preparation of a glyt1 inhibitor
04/09/2008EP1907362A1 Amide derivatives as kinase inhibitors
04/02/2008EP1904473A1 Benzoheterocyclylethylcarboxamide derivatives
04/01/2008US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
03/2008
03/27/2008WO2008035737A1 4-nitrobenzoyl derivative having sulfoxyimino group and herbicide for rice plant
03/26/2008EP1903041A2 Polymorphic and other crystalline forms of cis-FTC
03/26/2008CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives
03/26/2008CN101148446A L-configuration hexa-member heterocycle glycosyl pyrimidine nucleoside derivatives and preparation method thereof
03/19/2008CN101146769A Azolylacylguanidines as beta-secretase inhibitors
03/18/2008CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
03/12/2008CN101142211A Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
03/06/2008WO2007146225A3 Heterocyclic aspartyl protease inhibitors
02/2008
02/28/2008WO2008002868A3 Pyridinium salts for polymer composites and methods for their preparation
02/28/2008US20080051430 Dietetics; antidiabetic agents; sexual disorders
02/27/2008EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
02/27/2008CN101133052A 1-arylpyrazoles and their use as pesticides
02/26/2008US7335670 Specific inhibitors of the glycine transporters glyt1 and/or glyt2; psychoses, contracture, pain, Parkinson's disease, epilepsy, and sleep apnea
02/26/2008US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example
02/21/2008US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
02/14/2008US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
02/07/2008US20080033007 Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy
01/2008
01/31/2008WO2008013414A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
01/31/2008US20080027049 Benzofurans as potassium ion channel modulators
01/31/2008US20080027041 Pyridizinone derivatives
01/31/2008CA2658925A1 Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
01/23/2008EP1879878A2 New heterocyclylethylcarboxamide derivatives
01/17/2008US20080015202 Thiazole Derivatives Having Vap-1 Inhibitory Activity
01/10/2008WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/03/2008WO2007120729A3 Pyridyl amide t-type calcium channel antagonists
01/02/2008CN100358891C Pyranones useful as ATM inhibitors
01/01/2008US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide
12/2007
12/27/2007WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
12/27/2007US20070299051 Tricyclic Guanidine Derivatives as Sodium-Proton Exchange Inhibitors
12/27/2007US20070299050 TNF alpha inhibitors; inflammatory diseases such as rheumatoid arthritis, Crohn's disease, septic shock syndrome and atherosclerosis
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007CN100356979C Integrin expression inhibitors
12/25/2007US7312179 Cyclopropyl-thienyl-carboxamide as fungicides
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/19/2007EP1866303A1 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1´-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
12/06/2007US20070281950 1-((6-chloropyridin-3-yl)methyl)-8-nitro-1,2,3,5,6,7-hexahydro imidazo[1,2-a]pyridin-5-ol; 1-((6-chloropyridin-3-yl)methyl)-5-methoxy-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; increased photostability and liposolubility
12/05/2007CN101082058A Method of resolution and racemic mixture of nucleoside enantiomers
12/04/2007US7304168 For tracing/imaging molecular transfer between cellular gap junctions
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 25